For instance, triple-negative breast cancer (TNBC), characterized by the absence of the estrogen receptor (ER), progesterone receptor (PR), and epidermal growth factor receptor 2 (HER2) [8,9], is associated with a high risk of recurrence and poor prognosis [10,11]. Here, PGR is linked to triple-negative breast carcinoma.